194 related articles for article (PubMed ID: 38102305)
1. Feasibility of robotic platform to perform R0 resection for locally advanced multi-visceral pelvic malignancy: an institutional experience on outcomes of robotic pelvic exenteration.
Saqib SU; Raza MZ; Twigg J; Altan O; Bajwa AA
Langenbecks Arch Surg; 2023 Dec; 409(1):9. PubMed ID: 38102305
[TBL] [Abstract][Full Text] [Related]
2. Robotic pelvic exenteration and extended pelvic resections for locally advanced or synchronous rectal and urological malignancy.
Williams M; Perera M; Nouhaud FX; Coughlin G
Investig Clin Urol; 2021 Jan; 62(1):111-120. PubMed ID: 33381928
[TBL] [Abstract][Full Text] [Related]
3. Robotic multivisceral pelvic resection: experience from an exenteration unit.
Smith N; Murphy DG; Lawrentschuk N; McCormick J; Heriot A; Warrier S; Lynch AC
Tech Coloproctol; 2020 Nov; 24(11):1145-1153. PubMed ID: 32662050
[TBL] [Abstract][Full Text] [Related]
4. Minimally Invasive Surgery for Pelvic Exenteration in Primary Colorectal Cancer.
Kumar NA; Sasi SP; Shinde RS; Verma K; Sugoor P; Desouza A; Engineer R; Saklani A
JSLS; 2020; 24(3):. PubMed ID: 32714002
[TBL] [Abstract][Full Text] [Related]
5. Robotic beyond total mesorectal excision surgery for primary and recurrent pelvic malignancy: Feasibility and short-term outcomes.
Larach JT; Flynn J; Fernando D; Mohan H; Rajkomar A; Waters PS; Kong J; McCormick JJ; Heriot AG; Warrier SK
Colorectal Dis; 2022 Jul; 24(7):821-827. PubMed ID: 35373888
[TBL] [Abstract][Full Text] [Related]
6. Feasibility of laparoscopic-assisted transanal pelvic exenteration in locally advanced rectal cancer with anterior invasion.
Nonaka T; Tominaga T; Akazawa Y; Sawai T; Nagayasu T
Tech Coloproctol; 2021 Jan; 25(1):69-74. PubMed ID: 32815047
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of transanal minimally invasive surgery for total pelvic exenteration for advanced primary and recurrent pelvic malignancies.
Beppu N; Ito K; Otani M; Imada A; Matsubara T; Song J; Kimura K; Kataoka K; Kuwahara R; Horio Y; Uchino M; Ikeuchi H; Ikeda M
Tech Coloproctol; 2023 Dec; 27(12):1367-1375. PubMed ID: 37878167
[TBL] [Abstract][Full Text] [Related]
8. Survival and morbidity outcomes after pelvic exenteration for pelvic sarcoma: an institutional series.
Lee PJ; Meshkat B; Sasidharan P; Zahid A; Coker DJ; Solomon MJ
ANZ J Surg; 2022 May; 92(5):1038-1043. PubMed ID: 34661958
[TBL] [Abstract][Full Text] [Related]
9. Pelvic Exenteration for Advanced Nonrectal Pelvic Malignancy.
PelvExCollaborative
Ann Surg; 2019 Nov; 270(5):899-905. PubMed ID: 31634184
[TBL] [Abstract][Full Text] [Related]
10. Cystoprostatectomy versus prostatectomy alone for locally advanced or recurrent pelvic cancer.
Turner GA; Harris CA; Eglinton TW; Wakeman CJ; Kueppers F; Dixon L; Dobbs BR; Frizelle FA
ANZ J Surg; 2016; 86(1-2):54-8. PubMed ID: 25113257
[TBL] [Abstract][Full Text] [Related]
11. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of using basement membrane biological products in pelvic floor reconstruction during pelvic exenteration].
Chen GL; Wang YL; Zhang X; Tao Y; Sun YH; Chen JN; Wang SQ; Su N; Wang ZG; Zhang J
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):268-276. PubMed ID: 36925127
[No Abstract] [Full Text] [Related]
13. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
[TBL] [Abstract][Full Text] [Related]
14. Application of minimally invasive approaches to pelvic exenteration for locally advanced and locally recurrent pelvic malignancy - A narrative review of outcomes in an evolving field.
Casey L; Larach JT; Waters PS; Kong JC; McCormick JJ; Heriot AG; Warrier SK
Eur J Surg Oncol; 2022 Nov; 48(11):2330-2337. PubMed ID: 36068124
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive pelvic exenteration for gynaecological malignancy: A single-centre case series and review of the literature.
Karkia R; Tailor A; Ellis P; Madhuri T; Scala A; Read J; Perry M; Patil K; Blackburn A; Butler-Manuel S; Chatterjee J
Eur J Obstet Gynecol Reprod Biol; 2022 Jul; 274():56-61. PubMed ID: 35584578
[TBL] [Abstract][Full Text] [Related]
16. Salvage robotic anterior pelvic exenteration for cervical cancer: technique and feasibility.
Jain V; Debnath S; Rawal S
J Robot Surg; 2021 Dec; 15(6):945-953. PubMed ID: 33515209
[TBL] [Abstract][Full Text] [Related]
17. [Observational study on perioperative outcomes of pelvic exenteration].
Yuan H; Yao B; Li JT; Zhu WL; Ren DL; Wang H; Ma TH; Chen SQ; Wu JJ; Tao YR; Ye L; Wang ZY; Qu H; Ma B; Zhong WW; Wang DJ; Qiu JG
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 Mar; 26(3):260-267. PubMed ID: 36925126
[No Abstract] [Full Text] [Related]
18. Minimally invasive versus open pelvic exenterations for rectal cancer: a comparative analysis of perioperative and 3-year oncological outcomes.
Kazi M; Kumar NAN; Rohila J; Sukumar V; Engineer R; Ankathi S; Desouza A; Saklani A
BJS Open; 2021 Sep; 5(5):. PubMed ID: 34518872
[TBL] [Abstract][Full Text] [Related]
19. Laparoscopic Pelvic Exenteration for Locally Advanced Rectal Cancer, Technique and Short-Term Outcomes.
Pokharkar A; Kammar P; D'souza A; Bhamre R; Sugoor P; Saklani A
J Laparoendosc Adv Surg Tech A; 2018 Dec; 28(12):1489-1494. PubMed ID: 29741977
[No Abstract] [Full Text] [Related]
20. Disease-free survival after robotic-assisted laparoscopic total pelvic exenteration for recurrent cervical adenocarcinoma: A case report.
Yang Q; Tang J; Xiao L
Medicine (Baltimore); 2018 Jul; 97(30):e11611. PubMed ID: 30045297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
